NaikRPStreiffMBHaywoodCSegalJBLanzkronS.Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication. Am J Med. 2013;126:443-449.
2.
BüllerHRPrinsMHLensinAW. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012;366:1287-1297.
3.
BauersachsRBerkowitzSDBrennerB. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363:2499-2510.
4.
SparkenbaughEMChantrathammachartPMickelsonJ. Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease. Blood. 2014;123:1747-1756.
5.
SiegalDMCurnutteJTConnollySJ. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015;373:2413-2424.
